These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Beier UH; Wang L; Han R; Akimova T; Liu Y; Hancock WW Sci Signal; 2012 Jun; 5(229):ra45. PubMed ID: 22715468 [TBL] [Abstract][Full Text] [Related]
3. Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models. Shen L; Ciesielski M; Ramakrishnan S; Miles KM; Ellis L; Sotomayor P; Shrikant P; Fenstermaker R; Pili R PLoS One; 2012; 7(1):e30815. PubMed ID: 22303460 [TBL] [Abstract][Full Text] [Related]
4. Histone/protein deacetylase inhibitor therapy for enhancement of Foxp3+ T-regulatory cell function posttransplantation. Wang L; Beier UH; Akimova T; Dahiya S; Han R; Samanta A; Levine MH; Hancock WW Am J Transplant; 2018 Jul; 18(7):1596-1603. PubMed ID: 29603600 [TBL] [Abstract][Full Text] [Related]
5. Abnormal acetylation of FOXP3 regulated by SIRT-1 induces Treg functional deficiency in patients with abdominal aortic aneurysms. Jiang H; Xin S; Yan Y; Lun Y; Yang X; Zhang J Atherosclerosis; 2018 Apr; 271():182-192. PubMed ID: 29524861 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells. de Zoeten EF; Wang L; Butler K; Beier UH; Akimova T; Sai H; Bradner JE; Mazitschek R; Kozikowski AP; Matthias P; Hancock WW Mol Cell Biol; 2011 May; 31(10):2066-78. PubMed ID: 21444725 [TBL] [Abstract][Full Text] [Related]
7. Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells. Beier UH; Akimova T; Liu Y; Wang L; Hancock WW Curr Opin Immunol; 2011 Oct; 23(5):670-8. PubMed ID: 21798734 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors and transplantation. Tao R; de Zoeten EF; Ozkaynak E; Wang L; Li B; Greene MI; Wells AD; Hancock WW Curr Opin Immunol; 2007 Oct; 19(5):589-95. PubMed ID: 17719760 [TBL] [Abstract][Full Text] [Related]
9. FOXP3 ensembles in T-cell regulation. Li B; Samanta A; Song X; Furuuchi K; Iacono KT; Kennedy S; Katsumata M; Saouaf SJ; Greene MI Immunol Rev; 2006 Aug; 212():99-113. PubMed ID: 16903909 [TBL] [Abstract][Full Text] [Related]
10. Rationale for HDAC inhibitor therapy in autoimmunity and transplantation. Hancock WW Handb Exp Pharmacol; 2011; 206():103-23. PubMed ID: 21879448 [TBL] [Abstract][Full Text] [Related]
12. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. van Loosdregt J; Vercoulen Y; Guichelaar T; Gent YY; Beekman JM; van Beekum O; Brenkman AB; Hijnen DJ; Mutis T; Kalkhoven E; Prakken BJ; Coffer PJ Blood; 2010 Feb; 115(5):965-74. PubMed ID: 19996091 [TBL] [Abstract][Full Text] [Related]
13. Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells. Kalin JH; Butler KV; Akimova T; Hancock WW; Kozikowski AP J Med Chem; 2012 Jan; 55(2):639-51. PubMed ID: 22165909 [TBL] [Abstract][Full Text] [Related]
14. Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs. Akimova T; Ge G; Golovina T; Mikheeva T; Wang L; Riley JL; Hancock WW Clin Immunol; 2010 Sep; 136(3):348-63. PubMed ID: 20478744 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Histone Deacetylase 6 Reveals a Potent Immunosuppressant Effect in Models of Transplantation. Ellis JD; Neil DA; Inston NG; Jenkinson E; Drayson MT; Hampson P; Shuttleworth SJ; Ready AR; Cobbold M Transplantation; 2016 Aug; 100(8):1667-74. PubMed ID: 27222932 [TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells. Wang L; de Zoeten EF; Greene MI; Hancock WW Nat Rev Drug Discov; 2009 Dec; 8(12):969-81. PubMed ID: 19855427 [TBL] [Abstract][Full Text] [Related]
17. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance. Wang L; Tao R; Hancock WW Immunol Cell Biol; 2009; 87(3):195-202. PubMed ID: 19172156 [TBL] [Abstract][Full Text] [Related]
18. Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity. Zhang H; Xiao Y; Zhu Z; Li B; Greene MI Immunol Cell Biol; 2012 Jan; 90(1):95-100. PubMed ID: 22124370 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans. Choi SW; Gatza E; Hou G; Sun Y; Whitfield J; Song Y; Oravecz-Wilson K; Tawara I; Dinarello CA; Reddy P Blood; 2015 Jan; 125(5):815-9. PubMed ID: 25428224 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor regulates the balance of Th17/Treg in allergic asthma. Hou X; Wan H; Ai X; Shi Y; Ni Y; Tang W; Shi G Clin Respir J; 2016 May; 10(3):371-9. PubMed ID: 25307458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]